Litcius/Paper detail

D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

Ziming Li, Zhengbo Song, Yanqiu Zhao, Pingli Wang, Liyan Jiang, Yi Gong, Jianying Zhou, Hong Jian, Xiaorong Dong, Zhuang Wu, Shundong Cang, Nong Yang, Jian Fang, Jianhua Shi, Jun‐Guo Lu, Rui Ma, Ping Wu, Yingqian Zhang, Mengmeng Song, Chunwei Xu, Zhe Shi, Ling Zhang, Yaolin Wang, Xicheng Wang, Yiping Zhang, Shun Lü

2023Journal of Thoracic Oncology81 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePharmacologyOncologyInternal medicineProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK PathwaysColorectal Cancer Treatments and Studies
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results | Litcius